NDC11 69097066103
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69097-0661-03 | 69097-0661 |
| 69097-0661-3 | 69097-0661 |
| 69097-661-03 | 69097-661 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fluticasone propionate and Salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | Cipla USA Inc. | 1349a04c-2024-42b9-b81d-a7d995716ade | 2026-04-01 | Warnings, Adverse reactions | 69097-661-03 69097-661 69097066103 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.